India to Laos: Lenvatinib Export Trade Route

The India to Laos Lenvatinib corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $1.4K USD. The route is dominated by ASPIDA LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's lenvatinib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $469 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with lenvatinib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 22.6%, placing it at rank #20 among India's top lenvatinib export destinations globally.

On the import side, key buyers of Indian lenvatinib in Laos include MS KHUAN SAIMANEEBIGBANG INTERNATIONAL TRADE CO LIMITED, ALLIEVA PHARMA LAO CO LTD. MS KHUAN SAIMANEEBIGBANG INTERNATIONAL TRADE CO LIMITED is the single largest importer with 1 shipments valued at $741 USD.

India's lenvatinib exports to Laos are driven primarily by a handful of large-scale manufacturers. ASPIDA LIFE SCIENCES PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Laos benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ASPIDA LIFE SCIENCES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $469 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptionlenvatinib capsules 10 mg 1*30 capsuleslenvalieva 10mg batch no . blvc220 and harmless medicine for human consumptionlenvatinib capsules 4 mg 1*30 capsuleslenvalieva 4 mg batch no . blvc2301za, suggesting that buyers in Laos tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MS KHUAN SAIMANEEBIGBANG INTERNATIONAL TRADE CO LIMITED is the largest importer with 1 shipments worth $741 USD — representing 53% of all lenvatinib imports from India on this route.